share_log

金城医药(300233.SZ):未开展TMA的研究

Jincheng Pharmaceutical (300233.SZ): No TMA studies have been conducted

Gelonghui Finance ·  May 17 04:13

Gelonghui, May 17 | Jincheng Pharmaceutical (300233.SZ) said on the investor interactive platform that currently the company has not carried out TMA research, and in terms of technology, it can be produced using an enzymatic catalytic process in terms of synthesis.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment